Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Mean levels of vitamin D in the pre: and post-COVID groups (26.37 ng/mL vs. 25.67 ng/mL; p = 0.24) were comparable; however, there were more subjects with vitamin D severe deficiency or deficiency in the post-COVID group compared to the pre-COVID group (severe deficiency or deficiency: 40% vs. 36%; OR = 1.38, p = 0.01). (Figure 1) When studying different age groups, the 1 to 5 years and 6 to 12 years subgroups showed a significantly larger proportion of subjects with severely deficient or deficient vitamin D in the post-COVID period, with a higher risk of vitamin D deficiency (1 to 5 years: severe deficiency or deficiency: 39% vs. 29%; OR = 1.57, p < 0.01; 6 to 12 years: severe deficiency or deficiency: 48% vs. 41%; OR = 1.30, p = 0.04). (Figure 1) (Table S1) On the other hand, infants did not show abnormal values in either period.

Source: 3. Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We retrospectively enrolled children aged 1 month to 17 years of age that had performed a routine measurement of serum vitamin D levels during a hospitalization or a day in hospital in any ward of the third level Pediatric Hospital Santobono: Pausilipon in Naples between 11 March 2019 and 11 March 2021.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D Levels in the Pre: and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age

Study design awaiting verification · Nutrients · 2023

Original publication title

Vitamin D Levels in the Pre: and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age

Caterina Mosca; Angelo Colucci; Fabio Savoia; Camilla Calì; Margherita Del Bene; Giusy Ranucci; Antonio Maglione; Angela Pepe; Annalisa Morelli; Pietro Vajro; Claudia Mandato

© 2023 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Coronavirus disease 2019 (COVID-19) restrictions have been correlated with vitamin D deficiency in children, but some uncertainties remain. We retrospectively studied vitamin 25-(OH) D blood levels in 2182 Italian children/adolescents hospitalized for various chronic diseases in the year before (n = 1052) and after (n = 1130) the nationwide lockdown. The type of underlying disease, gender, and mean age (91 ± 55 and 91 ± 61 months, respectively) of patients included in the two periods were comparable. Although mean levels were the same (p = 0.24), deficiency status affected a significantly higher number of subjects during the lockdown period than in the pre-COVID period (p = 0.03), particularly in summer (p = 0.02), and there was also a smoothing of seasonal variations in vitamin D levels.

Particularly at risk were males (OR = 1.22; p = 0.03), the 1 to 5 year age group (OR = 1.57; p < 0.01) and the 6 to 12 year age group (OR = 1.30; p = 0.04). Infants appeared not to be affected (p = 1.00). In the post-COVID period, the risk of vitamin D deficiency was unchanged in disease-specific groups. However, the proportion of deficiency or severe deficiency differed significantly in the subgroup with endocrinopathy (higher; Chi-square p = 0.04), and with respiratory problems and obesity (lower; Chi-square p = 0.01 and p < 0.01, respectively).

Conflicting/opposite literature results advocate for further studies to clearly indicate the need for supplementation during possible future periods of confinement.

Authors’ abstract

Coronavirus disease 2019 (COVID-19) restrictions have been correlated with vitamin D deficiency in children, but some uncertainties remain. We retrospectively studied vitamin 25-(OH) D blood levels in 2182 Italian children/adolescents hospitalized for various chronic diseases in the year before (n = 1052) and after (n = 1130) the nationwide lockdown. The type of underlying disease, gender, and mean age (91 ± 55 and 91 ± 61 months, respectively) of patients included in the two periods were comparable. Although mean levels were the same (p = 0.24), deficiency status affected a significantly higher number of subjects during the lockdown period than in the pre-COVID period (p = 0.03), particularly in summer (p = 0.02), and there was also a smoothing of seasonal variations in vitamin D levels.

Particularly at risk were males (OR = 1.22; p = 0.03), the 1 to 5 year age group (OR = 1.57; p < 0.01) and the 6 to 12 year age group (OR = 1.30; p = 0.04). Infants appeared not to be affected (p = 1.00). In the post-COVID period, the risk of vitamin D deficiency was unchanged in disease-specific groups. However, the proportion of deficiency or severe deficiency differed significantly in the subgroup with endocrinopathy (higher; Chi-square p = 0.04), and with respiratory problems and obesity (lower; Chi-square p = 0.01 and p < 0.01, respectively).

Conflicting/opposite literature results advocate for further studies to clearly indicate the need for supplementation during possible future periods of confinement.

Publication and source details

Original title: Vitamin D Levels in the Pre: and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age

Caterina Mosca; Angelo Colucci; Fabio Savoia; Camilla Calì; Margherita Del Bene; Giusy Ranucci; Antonio Maglione; Angela Pepe; Annalisa Morelli; Pietro Vajro; Claudia Mandato

Nutrients · 2023

* Correspondence: acolucci@unisa.it (A.C.); pietro.vajro@gmail.com (P.V.); Tel.: +39-3498139708 (A.C.)
†

These authors contributed equally to this work.

© 2023 by the authors.2023https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T07:16:38.370854+00:00

DOI: 10.3390/nu15092089 · PMC10181113